269 related articles for article (PubMed ID: 29413276)
1. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial.
Xu Y; Rong X; Hu W; Huang X; Li Y; Zheng D; Cai Z; Zuo Z; Tang Y
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1087-1095. PubMed ID: 29885994
[TBL] [Abstract][Full Text] [Related]
3. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
Khan M; Zhao Z; Arooj S; Liao G
BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
[TBL] [Abstract][Full Text] [Related]
5. Effect of bevacizumab on radiation necrosis of the brain.
Gonzalez J; Kumar AJ; Conrad CA; Levin VA
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):323-6. PubMed ID: 17236958
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
[TBL] [Abstract][Full Text] [Related]
7. Comparison between high-dose and low-dose intravenous methylprednisolone therapy in patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
Zhuo X; Huang X; Yan M; Li H; Li Y; Rong X; Lin J; Cai J; Xie F; Xu Y; Chen K; Tang Y
Radiother Oncol; 2019 Aug; 137():16-23. PubMed ID: 31048233
[TBL] [Abstract][Full Text] [Related]
8. Temporal Cerebral Microbleeds Are Associated With Radiation Necrosis and Cognitive Dysfunction in Patients Treated for Nasopharyngeal Carcinoma.
Shen Q; Lin F; Rong X; Yang W; Li Y; Cai Z; Xu P; Xu Y; Tang Y
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1113-20. PubMed ID: 27026315
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab alleviates radiation-induced brain necrosis: A report of four cases.
Xiang-Pan L; Yuxin C; Xiao-Fei W; Na L; Tang-Peng X; Xiao-Tao X; Chang-Li R; Wei-Guo H; Qi-Bin S
J Cancer Res Ther; 2015; 11(2):485-7. PubMed ID: 26148625
[TBL] [Abstract][Full Text] [Related]
10. The correlation between serum apolipoprotein B/apolipoprotein A1 ratio and brain necrosis in patients underwent radiotherapy for nasopharyngeal carcinoma.
Li H; Zheng D; Xie F; Huang X; Zhuo X; Lin J; Li Y; Tang Y
Brain Behav; 2020 Mar; 10(3):e01554. PubMed ID: 32017458
[TBL] [Abstract][Full Text] [Related]
11. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ
Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323
[TBL] [Abstract][Full Text] [Related]
12. Single-shot bevacizumab for cerebral radiation injury.
Voss M; Wenger KJ; Fokas E; Forster MT; Steinbach JP; Ronellenfitsch MW
BMC Neurol; 2021 Feb; 21(1):77. PubMed ID: 33596839
[TBL] [Abstract][Full Text] [Related]
13. Divergent white matter changes in patients with nasopharyngeal carcinoma post-radiotherapy with different outcomes: a potential biomarker for prediction of radiation necrosis.
Lin X; Li Z; Chen S; Yang Y; He H; Lv X; Qiu Y
Eur Radiol; 2022 Oct; 32(10):7036-7047. PubMed ID: 35687134
[TBL] [Abstract][Full Text] [Related]
14. Diffusion Kurtosis as an in vivo Imaging Marker of Early Radiation-Induced Changes in Radiation-Induced Temporal Lobe Necrosis in Nasopharyngeal Carcinoma Patients.
Liyan L; Si W; Qian W; Yuhui S; Xiaoer W; Yuehua L; Wenbin L
Clin Neuroradiol; 2018 Sep; 28(3):413-420. PubMed ID: 28447147
[TBL] [Abstract][Full Text] [Related]
15. Evolution and Dosimetric Analysis of Magnetic Resonance Imaging-Detected Brain Stem Injury After Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
Huang XD; Li YC; Chen FP; Zheng WH; Zhou GQ; Lin L; Hu J; He WJ; Zhang LL; Kou J; Ma J; Zhang WD; Qi ZY; Sun Y
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):124-131. PubMed ID: 31075310
[TBL] [Abstract][Full Text] [Related]
16. Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
Dashti SR; Kadner RJ; Folley BS; Sheehan JP; Han DY; Kryscio RJ; Carter MB; Shields LBE; Plato BM; La Rocca RV; Spalding AC; Yao TL; Fraser JF
J Neurosurg; 2022 Dec; 137(6):1676-1686. PubMed ID: 35426830
[TBL] [Abstract][Full Text] [Related]
17. Radiation retinopathy after external beam irradiation for nasopharyngeal carcinoma: A case report and review of the literature.
Bawankar P; Barman M; Bhattacharjee H; Soibam R; Paulbuddhe V
Pract Radiat Oncol; 2018; 8(6):366-368. PubMed ID: 29861351
[No Abstract] [Full Text] [Related]
18. Blood-Brain Barrier Repair of Bevacizumab and Corticosteroid as Prediction of Clinical Improvement and Relapse Risk in Radiation-Induced Brain Necrosis: A Retrospective Observational Study.
Xue R; Chen M; Cai J; Deng Z; Pan D; Liu X; Li Y; Rong X; Li H; Xu Y; Shen Q; Tang Y
Front Oncol; 2021; 11():720417. PubMed ID: 34692494
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
[TBL] [Abstract][Full Text] [Related]
20. Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases.
Sujijantarat N; Hong CS; Owusu KA; Elsamadicy AA; Antonios JP; Koo AB; Baehring JM; Chiang VL
J Neurooncol; 2020 Jul; 148(3):641-649. PubMed ID: 32602021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
